- Home
- SRZN vs FONR Comparison
SRZN vs FONR Comparison
Compare SRZN & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRZN
- FONR
- Stock Information
- Founded
- SRZN 2015
- FONR 1978
- Country
- SRZN United States
- FONR United States
- Employees
- SRZN N/A
- FONR N/A
- Industry
- SRZN Medicinal Chemicals and Botanical Products
- FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SRZN Health Care
- FONR Health Care
- Exchange
- SRZN Nasdaq
- FONR Nasdaq
- Market Cap
- SRZN 72.8M
- FONR 77.1M
- IPO Year
- SRZN N/A
- FONR 1987
- Fundamental
- Price
- SRZN $10.00
- FONR $14.18
- Analyst Decision
- SRZN Strong Buy
- FONR
- Analyst Count
- SRZN 2
- FONR 0
- Target Price
- SRZN $38.50
- FONR N/A
- AVG Volume (30 Days)
- SRZN 15.0K
- FONR 31.4K
- Earning Date
- SRZN 08-11-2025
- FONR 05-15-2025
- Dividend Yield
- SRZN N/A
- FONR N/A
- EPS Growth
- SRZN N/A
- FONR N/A
- EPS
- SRZN N/A
- FONR 1.28
- Revenue
- SRZN $11,638,000.00
- FONR $103,018,089.00
- Revenue This Year
- SRZN N/A
- FONR N/A
- Revenue Next Year
- SRZN N/A
- FONR N/A
- P/E Ratio
- SRZN N/A
- FONR $11.11
- Revenue Growth
- SRZN N/A
- FONR 0.29
- 52 Week Low
- SRZN $5.90
- FONR $12.00
- 52 Week High
- SRZN $18.17
- FONR $18.68
- Technical
- Relative Strength Index (RSI)
- SRZN 61.67
- FONR 53.63
- Support Level
- SRZN $9.15
- FONR $14.10
- Resistance Level
- SRZN $10.05
- FONR $14.60
- Average True Range (ATR)
- SRZN 0.53
- FONR 0.38
- MACD
- SRZN 0.20
- FONR -0.10
- Stochastic Oscillator
- SRZN 93.33
- FONR 40.58
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
About FONR Fonar Corporation
Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.